Toward a personalized therapy for panic disorder: preliminary considerations from a work in progress.

evidence-based panic pharmacotherapy somatic

Journal

Neuropsychiatric disease and treatment
ISSN: 1176-6328
Titre abrégé: Neuropsychiatr Dis Treat
Pays: New Zealand
ID NLM: 101240304

Informations de publication

Date de publication:
2019
Historique:
received: 15 03 2019
accepted: 20 06 2019
entrez: 3 8 2019
pubmed: 3 8 2019
medline: 3 8 2019
Statut: epublish

Résumé

Although several treatment options for panic disorder (PD) are available, the best intervention for each individual patient remains uncertain and the use of a more personalized therapeutic approach in PD is required. In clinical practice, clinicians combine general scientific information and personal experience in the decision-making process to choose a tailored treatment for each patient. In this sense, clinicians already use a somehow personalized medicine strategy. However, the influence of their interpretative personal models may lead to bias related to personal convictions, not sufficiently grounded on scientific evidence. Hence, an effort to give some advice based on the science of personalized medicine could have positive effects on clinicians' decisions. Based on a narrative review of meta-analyses, systematic reviews, and experimental studies, we proposed a first-step attempt of evidence-based personalized therapy for PD. We focused on some phenomenological profiles, encompassing symptoms during/outside panic attacks, related patterns of physiological functions, and some aspects of physical health, which might be worth considering when developing treatment plans for patients with PD. We considered respiratory, cardiac, vestibular, and derealization/depersonalization profiles, with related implications for treatment. Given the extensiveness of the topic, we considered only medications and some somatic interventions. Our proposal should be considered neither exhaustive nor conclusive, as it is meant as a very preliminary step toward a future, robust evidence-based personalized therapy for PD. Clearly much more work is needed to achieve this goal, and recent technological advances, such as wearable devices, big data platforms, and the application of machine learning techniques, may help obtain reliable findings. We believe that combining the efforts of different research groups in this work in progress can lead to largely shared conclusions in the near future.

Identifiants

pubmed: 31371969
doi: 10.2147/NDT.S174433
pii: 174433
pmc: PMC6628946
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

1957-1970

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Am J Psychiatry. 1999 May;156(5):739-44
pubmed: 10327907
Neuropsychobiology. 1999 Sep;40(3):124-8
pubmed: 10494046
Depress Anxiety. 2000;11(3):126-30
pubmed: 10875054
Psychol Rev. 2001 Jan;108(1):4-32
pubmed: 11212632
Biol Psychiatry. 2001 Apr 1;49(7):596-605
pubmed: 11297717
J Anxiety Disord. 2001 Jan-Apr;15(1-2):131-46
pubmed: 11388356
Pharmacopsychiatry. 2001 May;34(3):85-90
pubmed: 11434404
J Psychiatr Res. 2001 Sep-Oct;35(5):279-86
pubmed: 11591430
Arch Otolaryngol Head Neck Surg. 2002 May;128(5):554-60
pubmed: 12003587
J Clin Psychopharmacol. 2002 Jun;22(3):300-8
pubmed: 12006901
Depress Anxiety. 2002;15(4):172-5
pubmed: 12112722
Braz J Med Biol Res. 2002 Jul;35(7):783-8
pubmed: 12131917
Psychiatry Res. 2002 Nov 15;112(3):269-72
pubmed: 12450637
J Clin Psychopharmacol. 2003 Feb;23(1):106-8
pubmed: 12544387
Depress Anxiety. 2003;17(2):101-6
pubmed: 12621600
J Asthma. 2003 Apr;40(2):139-45
pubmed: 12765315
Psychol Med. 2003 Jul;33(5):879-85
pubmed: 12877402
Can J Psychiatry. 2003 Jul;48(6):381-7
pubmed: 12894612
J Psychosom Res. 2003 Dec;55(6):507-13
pubmed: 14642980
Neuropsychobiology. 2004;49(2):53-7
pubmed: 14981334
J Clin Psychopharmacol. 2004 Jun;24(3):277-82
pubmed: 15118481
Pharmacopsychiatry. 2004 Sep;37(5):206-10
pubmed: 15359375
Biol Psychiatry. 2004 Sep 15;56(6):393-8
pubmed: 15364036
Am J Respir Crit Care Med. 2005 Jun 1;171(11):1224-30
pubmed: 15764721
Psychiatry Res. 2005 Nov 15;137(1-2):61-70
pubmed: 16226812
J Psychiatr Res. 2006 Sep;40(6):520-7
pubmed: 16293263
J Clin Psychopharmacol. 2006 Oct;26(5):538-40
pubmed: 16974205
J Psychiatr Res. 2008 Jun;42(7):560-8
pubmed: 17681544
J Affect Disord. 2008 Apr;107(1-3):217-20
pubmed: 17727960
Acta Otorhinolaryngol Ital. 2007 Oct;27(5):243-7
pubmed: 18198754
J Psychiatr Res. 2009 Mar;43(6):634-41
pubmed: 18835608
J Psychopharmacol. 2009 Sep;23(7):826-30
pubmed: 19074543
Acta Psychiatr Scand. 2009 Sep;120(3):167-77
pubmed: 19548964
J Bras Pneumol. 2009 Jul;35(7):698-708
pubmed: 19669009
Depress Anxiety. 2009;26(10):878-87
pubmed: 19750553
J Affect Disord. 2010 Jul;124(1-2):215-8
pubmed: 19896718
J Laryngol Otol. 2010 Mar;124(3):285-90
pubmed: 19954562
J Clin Psychiatry. 2010 May;71(5):606-15
pubmed: 19961810
Respir Med. 2010 Sep;104(9):1246-53
pubmed: 20457513
Harv Rev Psychiatry. 2010 Jul-Aug;18(4):220-9
pubmed: 20597592
Neuropsychobiology. 2010 Aug;62(3):164-70
pubmed: 20628267
Biol Psychol. 2010 Oct;85(2):226-32
pubmed: 20637257
J Consult Clin Psychol. 2010 Oct;78(5):691-704
pubmed: 20873904
Psychiatry Res. 2011 May 30;187(3):387-91
pubmed: 21477868
Arq Neuropsiquiatr. 2011 Apr;69(2A):196-201
pubmed: 21537560
Psychol Med. 2011 Nov;41(11):2411-21
pubmed: 21557895
Biol Psychiatry. 2011 Nov 15;70(10):985-91
pubmed: 21783179
Psychol Med. 2012 Mar;42(3):461-74
pubmed: 21846423
Int J Psychiatry Clin Pract. 2012 Mar;16(1):27-32
pubmed: 22122655
Neuro Endocrinol Lett. 2011;32(5):641-51
pubmed: 22167145
Braz J Psychiatry. 2011 Dec;33(4):385-9
pubmed: 22189929
Behav Ther. 2012 Mar;43(1):203-15
pubmed: 22304891
J Clin Psychiatry. 2012 Jul;73(7):931-9
pubmed: 22901344
J Affect Disord. 2013 Apr 5;146(2):158-73
pubmed: 23107756
Clinics (Sao Paulo). 2012 Nov;67(11):1291-7
pubmed: 23184206
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:34-9
pubmed: 23643675
J Psychiatr Res. 2013 Oct;47(10):1357-62
pubmed: 23806579
Braz J Psychiatry. 2014 Jan-Mar;36(1):68-75
pubmed: 24604463
J Affect Disord. 2014 Aug;164:63-8
pubmed: 24856555
J Clin Psychiatry. 2014 May;75(5):e441-9
pubmed: 24922496
Psychiatry Res. 2014 Oct 30;219(2):311-5
pubmed: 24953422
Front Psychiatry. 2014 Jul 11;5:80
pubmed: 25071612
Neuropsychobiology. 2014;70(1):52-60
pubmed: 25247676
Psychiatry Investig. 2014 Oct;11(4):412-8
pubmed: 25395972
Neurosci Biobehav Rev. 2015 Jan;48:148-59
pubmed: 25451199
Depress Anxiety. 2015 Mar;32(3):221-8
pubmed: 25515221
Depress Anxiety. 2015 May;32(5):341-8
pubmed: 25774487
CNS Neurol Disord Drug Targets. 2015;14(5):627-35
pubmed: 25924997
J Psychiatr Res. 2015 Sep;68:377-83
pubmed: 26028550
Neuropsychiatr Dis Treat. 2015 Oct 13;11:2629-33
pubmed: 26508858
J Affect Disord. 2016 Apr;194:38-49
pubmed: 26802506
J Clin Psychiatry. 2016 Jan;77(1):e21-4
pubmed: 26845274
Neural Plast. 2016;2016:8457612
pubmed: 26881136
Psychol Health Med. 2017 Jan;22(1):110-120
pubmed: 26911387
Curr Psychiatry Rep. 2016 Nov;18(11):101
pubmed: 27671918
Neuropsychiatr Dis Treat. 2016 Sep 22;12:2435-2438
pubmed: 27703361
J Res Med Sci. 2016 Sep 01;21:66
pubmed: 27904611
Psychosom Med. 2017 Jun;79(5):576-584
pubmed: 28033197
Appl Psychophysiol Biofeedback. 2017 Mar;42(1):51-58
pubmed: 28194546
Behav Modif. 2017 Sep;41(5):665-682
pubmed: 28670907
BMJ Open Sport Exerc Med. 2017 Apr 22;3(1):e000164
pubmed: 28761695
Dialogues Clin Neurosci. 2017 Jun;19(2):93-107
pubmed: 28867934
Int Rev Psychiatry. 2017 Oct;29(5):436-444
pubmed: 28893114
Psychol Med. 2018 Apr;48(5):705-713
pubmed: 28967349
Curr Treat Options Psychiatry. 2017;4(4):371-386
pubmed: 29238651
J Affect Disord. 2018 Mar 1;228:91-96
pubmed: 29241050
Depress Anxiety. 2018 Apr;35(4):360-371
pubmed: 29244900
Am J Physiol Heart Circ Physiol. 2018 Jul 1;315(1):H6-H17
pubmed: 29522373
J Psychiatr Res. 2018 Jun;101:34-41
pubmed: 29539585
F1000Res. 2018 Mar 8;7:294
pubmed: 29623195
J Affect Disord. 2018 Aug 1;235:474-479
pubmed: 29680728
Expert Opin Pharmacother. 2018 Aug;19(12):1357-1368
pubmed: 30063164
Neuropsychobiology. 2018 Sep 17;:1-9
pubmed: 30223263
Front Neurosci. 2018 Oct 24;12:785
pubmed: 30459546
J Affect Disord. 2019 Mar 1;246:157-165
pubmed: 30583140
Psychosomatics. 2018 Dec 12;:null
pubmed: 30594312
J Nerv Ment Dis. 2019 Mar;207(3):184-187
pubmed: 30724830
Psychiatry Res. 1985 Jan;14(1):57-65
pubmed: 3921997
Br J Psychiatry. 1993 Aug;163:201-9
pubmed: 8075912
Biol Psychiatry. 1996 Nov 1;40(9):913-7
pubmed: 8896779
J Clin Psychopharmacol. 1997 Oct;17(5):370-6
pubmed: 9315988
Biol Psychiatry. 1997 Oct 1;42(7):625-30
pubmed: 9376459
Biol Psychiatry. 1997 Dec 1;42(11):982-91
pubmed: 9386849

Auteurs

Daniela Caldirola (D)

Humanitas University, 20090 Pieve Emanuele, Milan, Italy.
Department of Clinical Neurosciences, Hermanas Hospitalarias, Villa San Benedetto Menni Hospital, 22032 Albese Con Cassano, Como, Italy.

Giampaolo Perna (G)

Humanitas University, 20090 Pieve Emanuele, Milan, Italy.
Department of Clinical Neurosciences, Hermanas Hospitalarias, Villa San Benedetto Menni Hospital, 22032 Albese Con Cassano, Como, Italy.
Department of Psychiatry and Neuropsychology, Faculty of Health, Medicine and Life Sciences, Maastricht University, 6200 Maastricht, The Netherlands.
Department of Psychiatry and Behavioral Sciences, Leonard Miller School of Medicine, Miami University, Miami, FL 33136 -1015, USA.

Classifications MeSH